RIPOSTE: a framework for improving the design and analysis of laboratory-based research
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Lack of reproducibility is an ongoing problem in some areas of the biomedical sciences. Poor experimental design and a failure to engage with experienced statisticians at key stages in the design and analysis of experiments are two factors that contribute to this problem. The RIPOSTE (Reducing IrreProducibility in labOratory STudiEs) framework has been developed to support early and regular discussions between scientists and statisticians in order to improve the design, conduct and analysis of laboratory studies and, therefore, to reduce irreproducibility. This framework is intended for use during the early stages of a research project, when specific questions or hypotheses are proposed. The essential points within the framework are explained and illustrated using three examples (a medical equipment test, a macrophage study and a gene expression study). Sound study design minimises the possibility of bias being introduced into experiments and leads to higher quality research with more reproducible results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · cited 1×
“Bias towards publication of statistically significant results has been shown to be substantively greater for observational and laboratory-based studies than for randomised clinical trials (Easterbrook et al., 1991).”
BackgroundRaise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979 · cited 2×
“Lack of reproducibility (or ‘irreproducibility’) is an acknowledged problem within biomedicine that has recently been gaining increased attention (Begley and Ellis, 2012; Begley, 2013; The Economist, 2013; Macleod et al., 2014).”
BackgroundMoher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755 · cited 1×
“As a result, reporting guidelines were developed (Moher et al., 2001; Schulz et al., 2010) to promote the reporting of key methodological components and results that enable study bias to be assessed and to support evidence synthesis.”
BackgroundAvoidable waste in the production and reporting of research evidence
Chalmers, I., & Glasziou, P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60329-9 · Cited by 2,208
Believe it or not: how much can we rely on published data on potential drug targets?
Prinz, F., Schlange, T., & Asadullah, K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3439-c1 · Cited by 1,888 · cited 2×
“elifesciences.org FEATURE ARTICLE”
BackgroundCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Trials · doi:10.1186/1745-6215-11-32 · Cited by 1,871
Increasing value and reducing waste in research design, conduct, and analysis
Ioannidis, J. P. A., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., Schulz, K. F., & Tibshirani, R. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62227-8 · Cited by 1,597
Reducing waste from incomplete or unusable reports of biomedical research
Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62228-x · Cited by 1,319
Policy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247 · cited 1×
“Some journals are now actively promoting the submission of short follow-on reports (the Research Advance in eLife) or breakthrough articles where simple but important questions are addressed (Corey et al., 2014).”
Stegle, O., Parts, L., Piipari, M., Winn, J., & Durbin, R. (2012) · Nature Protocols · doi:10.1038/nprot.2011.457 · Cited by 1,049
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.02.005 · Cited by 1,022
Biomedical research: increasing value, reducing waste.
Macleod, M. R., Michie, S., Roberts, I., Dirnagl, U., Chalmers, I., Ioannidis, J. P. A., Salman, R. A.-S., Chan, A.-W., & Glasziou, P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62329-6 · Cited by 1,003
Multiple-laboratory comparison of microarray platforms
Irizarry, R. A., Warren, D., Spencer, F., Kim, I. F., Biswal, S., Frank, B. C., Gabrielson, E., Garcia, J. G. N., Geoghegan, J., Germino, G., et al. (2005) · Nature Methods · doi:10.1038/nmeth756 · Cited by 862 · cited 1×
“…retractions have also been highlighted (www. retractionwatch.com), increasing the focus on what contributes to the problem and how to tackle it (Irizarry et al., 2005; Baggerly and Coombes, 2009; Prinz et al., 2011; Sebastiani et al., 2011; Begley and Ellis, 2012; Lambert and Black, 2012;…”
BackgroundHow to Make More Published Research True
Ioannidis, J. P. A. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001747 · Cited by 760
Registered Reports: A Method to Increase the Credibility of Published Results
Nosek, B. A., & Lakens, D. (2014) · Social Psychology · doi:10.1027/1864-9335/a000192 · Cited by 716
McNutt, M. (2014) · Science · doi:10.1126/science.1250475 · Cited by 291
Announcement: Reducing our irreproducibility
(2013) · Nature · doi:10.1038/496398a · Cited by 243
A model for harmonizing flow cytometry in clinical trials
the FOCIS Human Immunophenotyping Consortium, Maecker, H. T., & McCoy, J. P. (2010) · Nature Immunology · doi:10.1038/ni1110-975 · Cited by 155 · cited 1×
“Ultimately, some level of variation should be anticipated to occur amongst operators or sites and this needs to be reported and accounted for (Barnhart et al., 2007; Maecker et al., 2011).”
BackgroundThe Time Has Come to Register Diagnostic and Prognostic Research
Altman, D. G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.220335 · Cited by 39
The practical effect of batch on genomic prediction
Parker, H. S., & Leek, J. T. (2012) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/1544-6115.1766 · Cited by 34
Research works printed but not linked: 21
- Altman, 2012, Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration, BMC Medicine, 10, 51, 10.1186/1741-7015-10-51 · DOI · Paper page
- Baggerly, 2009, Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology, Annals of Applied Statistics, 3, 1309, 10.1214/09-AOAS291 · DOI · Paper page
- Barnhart, 2007, Assessing individual agreement, Journal of Biopharmaceutical Statistics, 17, 697, 10.1080/10543400701329489 · doi:10.1080/10543400701329489
- Begley, 2013, Six red flags for suspect work, Nature, 497, 433, 10.1038/497433a · DOI · Paper page
- Bloom, 2014, Data access for the open access literature: PLOS's data policy, PLOS Biology, 12, e1001797, 10.1371/journal.pbio.1001797 · DOI · Paper page
- Bogardus, 1999, Clinical epidemiological quality in molecular genetic research - the need for methodological standards, Journal of the American Medical Association, 281, 1919, 10.1001/jama.281.20.1919 · DOI · Paper page
- Brazma, 2009, Minimum information about a microarray experiment (MIAME) - successes, failures, challenges, The Scientific World Journal, 9, 420, 10.1100/tsw.2009.57 · DOI · Paper page
- Corey, 2014, Breakthrough articles: putting science first, Nucleic Acids Research, 42, 11273, 10.1093/nar/gku853 · DOI
- Errington, 2014, An open investigation of the reproducibility of cancer biology research, eLife, 3, e04333, 10.7554/eLife.04333 · DOI · Paper page
- Freedman, 2014, The increasing urgency for standards in basic biologic research, Cancer Research, 74, 4024, 10.1158/0008-5472.CAN-14-0925 · DOI · Paper page
- Hooft, 2011, Prospective Registration of marker evaluation studies: time to act, Clinical Chemistry, 57, 1684, 10.1373/clinchem.2011.176230 · DOI
- Hurlbert, 1984, Pseudoreplication and the design of ecological field experiments, Ecological Monographs, 54, 187, 10.2307/1942661 · DOI · Paper page
- Institute of Medicine, 2012, Evolution of Translational Omics: Lessons Learned and the Path Forward
- Ioannidis, 2005, Why most published research findings are false, PLOS Medicine, 2, 696, 10.1371/journal.pmed.0020124 · DOI · Paper page
- Ioannidis, 2006, Journals should publish all ‘null’ results and should sparingly publish ‘positive’ results, Cancer Epidemiology Biomarkers & Prevention, 15, 186, 10.1158/1055-9965.EPI-05-0921 · DOI · Paper page
- Lambert, 2012, Learning from our GWAS mistakes: from experimental design to scientific method, Biostatistics, 13, 195, 10.1093/biostatistics/kxr055 · DOI · Paper page
- Morrison, 2014, Time to do something about reproducibility, eLife, 3, e03981, 10.7554/eLife.03981 · DOI · Paper page
- Piantadosi, 2005, Clinical Trials: A Methodological Perspective, 274, 10.1002/0471740136 · DOI · Paper page
- Sebastiani, 2011, Retraction, Science, 333, 404, 10.1126/science.333.6041.404-a · DOI
- The Economist, 2013, Unreliable research: trouble at the lab, The Economist (19 October 2013)
- Westgard, 1981, A multi-rule shewhart chart for quality-control in clinical-chemistry, Clinical Chemistry, 27, 493, 10.1093/clinchem/27.3.493 · DOI · Paper page
Cited by
Nextflow enables reproducible computational workflows
Di Tommaso, P., Chatzou, M., Floden, E. W., Barja, P. P., Palumbo, E., & Notredame, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3820 · Cited by 4,001
SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
Banerjee, A. K., Blanco, M. R., Bruce, E. A., Honson, D. D., Chen, L. M., Chow, A., Bhat, P., Ollikainen, N., Quinodoz, S. A., Loney, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.004 · Cited by 583
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017) · Physiological Reviews · doi:10.1152/physrev.00038.2016 · Cited by 333
The devil is in the details: incomplete reporting in preclinical animal research
Avey, M. T., Moher, D., Sullivan, K. J., Fergusson, D., Griffin, G., Grimshaw, J. M., Hutton, B., Lalu, M. M., Macleod, M., Marshall, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166733 · Cited by 130
Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge Gaps
Jarvis, M. F., & Williams, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.12.001 · Cited by 129
“basic scientific learnings and research concepts that are (or should be) contained in many postgraduate biomedical science training curriculums (see [27,28,83] as examples), there are intrinsic difficulties in the broad application of explicit guidelines to diverse areas of biomedical research (e.”
BackgroundMethodInfluential
Metadata
- Authors
- Masca, N. G., Hensor, E. M., Cornelius, V. R., Buffa, F. M., Marriott, H. M., Eales, J. M., Messenger, M. P., Anderson, A. E., Boot, C., Bunce, C., Goldin, R. D., Harris, J., Hinchliffe, R. F., Junaid, H., Kingston, S., Martin-Ruiz, C., Nelson, C. P., Peacock, J., Seed, P. T., Shinkins, B., Staples, K. J., Toombs, J., Wright, A. K., & Teare, M. D.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2015-05-07
- Volume
- 4
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2135770010
- Cited by
- 56
- References
- 20
- FWCI
- 12.39
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- National Institute for Health Research (Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, Biomedical Research Centre at Guys' and St. Thomas' NHS Foundation Trust and King's College London, Launching Careers Research Fellowship, Diagnostic Evidence Co-operative, Biomedical Research Centre at Newcastle upon Tyne Hospitals NHS Foundation Trust and University of Newcastle)
- Higher Education Funding Council for England
- British Heart Foundation (PG/12/9/29376)
- Arthritis Research UK
- Tommy's Baby Charity
- GlaxoSmithKline (Collaborative grant)
- British Medical Association (HC Roscoe Award 2013)
- Leonard Wolfson Experimental Neurology Centre
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.